INTERNATIONAL JOURNAL OF PHARMACEUTICS (PRINT)

Qualis

• A1

código do país

• NL

tipo

• journal

publicação venue de

• A scoping review to compare and contrast quality assurance aspects of L-asparaginase biosimilars.  632:122523-122533. 2023-01-01
• Aloe vera and copaiba oleoresin-loaded chitosan films for wound dressings: microbial permeation, cytotoxicity, and in vivo proof of concept.  1:122648. 2023-01-01
• Ameliorating the antiparasitic activity of the multifaceted drug ivermectin through a polymer nanocapsule formulation.  1:122965-1. 2023-01-01
• Amorphous solid dispersions in high-swelling, low-substituted hydroxypropyl cellulose for enhancing the delivery of poorly soluble drugs.  228:123122. 2023-01-01
• An update of nano-based drug delivery systems for cannabinoids: biopharmaceutical aspects & therapeutic applications.  635:122727. 2023-01-01
• Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens.  1:123074. 2023-01-01
• Borophosphate glasses as active agents for antimicrobial hydrogels.  00:123323-0. 2023-01-01
• Chronic exposure to nitric oxide sensitizes prostate cancer cells and improved ZnO/CisPt NPs cytotoxicity and selectivity.  1:1. 2023-01-01
• Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer.  635:122681. 2023-01-01
• Copaiba essential oil loaded-nanocapsules film as a potential candidate for treating skin disorders: preparation, characterization, and antibacterial properties.  1:12260. 2023-01-01
• Designing and characterization of curcumin-loaded nanotechnological dressings: A promising platform for skin burn treatment.  635:122712. 2023-01-01
• Development of 3D-printed subcutaneous implants using concentrated polymer/drug solutions.  631:122477. 2023-01-01
• Development of a microemulsion loaded with epoxy-α-lapachone against Leishmania (Leishmania) amazonensis murine infection.  17:122864-122870. 2023-01-01
• Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir.  642:123108. 2023-01-01
• Development of multifunctional sunscreens: Evaluation of Physico-mechanical and film-forming properties.  635:122705. 2023-01-01
• Development of trans-Chalcone loaded pectin/casein biodegradable microcapsules: Efficacy improvement in the management of experimental colitis.  642:123206. 2023-01-01
• Development, Characterization and Evidence of Anti-Endometriotic Activity of Phytocannabinoid-Rich Nanoemulsions.  --:123049-20. 2023-01-01
• DoE development of ionic gradient liposomes: A successful approach to improve encapsulation, prolong anesthesia and decrease the toxicity of etidocaine.  634:122672. 2023-01-01
• Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats.  634:122678. 2023-01-01
• Elastic cationic liposomes for vitamin C delivery: Development, characterization and skin absorption study.  638:122897. 2023-01-01
• Hyaluronic acid-conjugated liposomes loaded with dexamethasone: A promising approach for the treatment of inflammatory diseases.  1004:122946-122946. 2023-01-01
• Inclusion complex of ketoconazole and p-sulfonic acid calix[6]arene improves antileishmanial activity and selectivity against Leishmania amazonensis and Leishmania infantum.  634:122663-122673. 2023-01-01
• Isothermal titration calorimetry (ITC) as a promising tool in pharmaceutical nanotechnology.  00:123063. 2023-01-01
• Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs.  640:123019. 2023-01-01
• Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: a comparative study.  636:122853. 2023-01-01
• MULTILAYERED POLYMER COATING MODULATES MUCOADHESIVE AND BIOLOGICAL PROPERTIES OF CAMPTOTHECIN-LOADED LIPID NANOCAPSULES.  635:122792. 2023-01-01
• Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity.  633:1. 2023-01-01
• Nanofiber-coated implants: development and safety after intravitreal application in rabbits.  636:122809. 2023-01-01
• Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.  631:122535. 2023-01-01
• Negatively charged chitosan nanoparticles prepared by ionotropic gelation for encapsulation of positively charged proteins.  642:123164. 2023-01-01
• New weapons against the disease vector Aedes aegypti: from natural products to nanoparticles.  1:123221. 2023-01-01
• Novel technologies to improve the treatment of endodontic microbial infections: Inputs from a drug delivery perspective.  635:122794. 2023-01-01
• Optimizing Adjuvant Inhaled Chemotherapy: Synergistic Enhancement in Paclitaxel Cytotoxicity by Flubendazole Nanocrystals in a Cycle Model Approach.  1:123324-1. 2023-01-01
• PEGylated and functionalized polylactide-based nanocapsules: An overview.  636:122760. 2023-01-01
• Pharmacological applications of nitric oxide-releasing biomaterials in human skin.  630:122465. 2023-01-01
• Poly---caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice.  01:123147. 2023-01-01
• Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targeting corneal neovascularization.  2:122682. 2023-01-01
• Replicating endothelial shear stress in organ-on-a-chip for predictive hypericin photodynamic efficiency.  1:122629. 2023-01-01
• Reprogramming of tumor-associated macrophages by polyaniline-coated iron oxide nanoparticles applied to treatment of breast cancer.  636:122866. 2023-01-01
• The challenge of improving pterostilbene (PTS) solubility for solid and semi-solid dosage forms: The obtention of binary and ternary systems.  635:122736. 2023-01-01
• The role of aggregation and ionization in the chemical instability of Amphotericin B in aqueous methanol.  632:122586. 2023-01-01
• Thermoresponsive in-situ gel containing hyaluronic acid and indomethacin for the treatment of corneal chemical burn.  631:122468. 2023-01-01
• Topical hydrophilic gel with itraconazole-loaded polymeric nanomicelles improves wound healing in the treatment of feline sporotrichosis.  1:122619. 2023-01-01
• Treating atopic-dermatitis-like skin lesions in mice with gelatin-alginate films containing 1,4-anhydro-4-seleno-d-talitol (SeTal).  1:123174. 2023-01-01
• Unconventional and conventional Pickering emulsions: perspectives and challenges in skin applications.  636:122817. 2023-01-01
• ZEIN NANOPARTICLES FOR DRUG DELIVERY: PREPARATION METHODS AND BIOLOGICAL APPLICATIONS.  635:122754. 2023-01-01
• A critical review of traditional and advanced characterisation tools to drive formulators towards the rational development of 3D printed oral dosage forms.  628:122293. 2022-01-01
• A new oral self-emulsifying drug delivery system improves the antileishmania efficacy of fexinidazole in vivo.  1:122505-50. 2022-01-01
• An overview of the use of central venous catheters impregnated with drugs or with inorganic nanoparticles as a strategy in preventing infections.  615:121518-5. 2022-01-01
• Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery.  1:122231. 2022-01-01
• Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection.  1:121782-1. 2022-01-01
• Antioxidant, anti-inflammatory, and wound healing effects of topical silver-doped zinc oxide and silver oxide nanocomposites.  617:121620. 2022-01-01
• BIPHASIC DISSOLUTION COMBINED WITH MODIFIED CYLINDER METHOD-A NEW PROMISING METHOD FOR DISSOLUTION TEST IN DRUG-LOADED NANOEMULSIONS.  1:122554. 2022-01-01
• Chemically crosslinked guar gum hydrogels: An investigation on the water transport and its relationship with hydrocortisone release.  1:121626-1. 2022-01-01
• Drug-loaded mesoporous silica on carboxymethyl cellulose hydrogel: Development of innovative 3D printed hydrophilic films.  620:121750-121750. 2022-01-01
• Ent-kaurenoic acid-enriched Mikania glomerata leaves-complexed β-cyclodextrin: pharmaceutical development and in vivo antitumor activity in a sarcoma 180 mouse model.  630:122497. 2022-01-01
• Eutectic mixture and amorphous solid dispersion: Two different supersaturating drug delivery system strategies to improve griseofulvin release using saccharin.  615:121498. 2022-01-01
• Evaluation of the polymorphic forms of ritonavir and lopinavir in raw materials and co-milled systems.  628:122329. 2022-01-01
• Exploiting Mesoporous Silica, Silver And Gold Nanoparticles For Neurodegenerative Diseases Treatment.  624:121978. 2022-01-01
• Five decades of doxycycline: Does nanotechnology improve its properties?.  618:121655. 2022-01-01
• Glioblastoma Multiforme Targeted Delivery Of Docetaxel Using Bevacizumab-Modified Nanostructured Lipid Carriers Impair In Vitro Cell Growth And In Vivo Tumor Progression.  25:121682-121694. 2022-01-01
• Highly water-soluble dapsone nanocrystals: towards innovative preparations for an undermined drug.  1:122428. 2022-01-01
• Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: An exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution.  1:121456-1. 2022-01-01
• IgG functionalized polymeric nanoparticles for oral insulin administration.  622:121829. 2022-01-01
• Immediate release 3D printed oral dosage forms: how different polymers have been explored to reach suitable drug release behaviour.  625:122066. 2022-01-01
• In vitro antileishmanial activity of sustainable anacardic acid and cardol based silver nanoparticles on L. braziliensis.  1:1/121698-.. 2022-01-01
• Lemongrass (Cymbopogon citratus)-incorporated chitosan bioactive films for potential skincare applications.  628:122301-12. 2022-01-01
• Levofloxacin in nanostructured lipid carriers: preformulation and critical process parameters for a highly incorporated formulation.  626:122193. 2022-01-01
• Medicated Lacquer For Application On Adornments To Treat Affections In Aesthetic Perforations.  627:122240. 2022-01-01
• Mucoadhesive nanoemulsion enhances brain bioavailability of luteolin after intranasal administration and induces apoptosis to sh-sy5y neuroblastoma cells.  .:122142-.. 2022-01-01
• Nek1-inhibitor and temozolomide-loaded microfibers as a co-therapy strategy for glioblastoma treatment.  1:121584-1. 2022-01-01
• Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.  616:121563. 2022-01-01
• Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies.  628:122299. 2022-01-01
• Redispersible 3D printed nanomedicines: An original application of the semisolid extrusion technique.  624:122029. 2022-01-01
• Skin interaction, permeation, and toxicity of silica nanoparticles: Challenges and recent therapeutic and cosmetic advances.  3jan:1. 2022-01-01
• Structural, thermal, vibrational, solubility and DFT studies of a tolbutamide co-amorphous drug delivery system for treatment of diabetes.  615:121500-121512. 2022-01-01
• The use of natural gums to produce nano-based hydrogels and films for topical application.  626:122166. 2022-01-01
• Therapeutic implementation in arterial thrombosis with pulmonary administration of fucoidan microparticles containing acetylsalicylic acid.  622:1-11. 2022-01-01
• Toxicity of the polymeric excipients in geriatric polypharmacy.  622:121901. 2022-01-01
• Trilayer dissolving polymeric microneedle array loading Rose Bengal transfersomes as a novel adjuvant in early-stage cutaneous melanoma management.  627:122217. 2022-01-01
• (REVIEW) How to define the experimental conditions of skin permeation assays for drugs presenting biopharmaceutical limitations? The experience with testosterone.  607:120987. 2021-01-01
• A crossover clinical study to evaluate pain intensity from microneedle insertion in different parts of the oral cavity.  5:120050. 2021-01-01
• Acoustic levitation and high-resolution synchrotron X-ray powder diffraction: A fast screening approach of niclosamide amorphous solid dispersions.  1:120611-9. 2021-01-01
• Amorphous dispersions of flubendazole in hydroxypropyl methylcellulose: Formulation stability assisted by pair distribution function analysis.  600:120500-120500-8. 2021-01-01
• Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment.  602:120655-11. 2021-01-01
• Combining dexamethasone and TNF- siRNA within the same nanoparticles to enhance anti-inflammatory effect.  598:120381-120387. 2021-01-01
• Curcumin encapsulation in nanostructures for cancer therapy: a 10-year overview.  00:120534. 2021-01-01
• Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain.  596:120294. 2021-01-01
• Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.  600:120444. 2021-01-01
• Development of buccal film formulations and their mucoadhesive performance in biomimetic models.  610:121233. 2021-01-01
• EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles.  552:1-23. 2021-01-01
• Enhanced nail delivery of voriconazole-loaded nanomicelles by thioglycolic acid pretreatment: A study of protein dynamics and disulfide bond rupture.  602:120597. 2021-01-01
• Evaluation of polymer choice on immunogenicity of chitosan coated PLGA NPs with surface-adsorbed pneumococcal protein antigen PspA4Pro.  599:120407. 2021-01-01
• Extrusion-based 3D printing of oral solid dosage forms: Material requirements and equipment dependencies.  598:120361. 2021-01-01
• HIGHLIGHTS IN TARGETED NANOPARTICLES AS A DELIVERY STRATEGY FOR GLIOMAS TREATMENT.  604:120758-120781. 2021-01-01
• Highlights in poloxamer-based drug delivery systems as strategy at local application for vaginal infections.  1:120635. 2021-01-01
• How to define the experimental conditions of skin permeation assays for drugs presenting biopharmaceutical limitations? The experience with testosterone.  607:120987. 2021-01-01
• Influence of physical-mechanical properties on SPF in sunscreen formulations on ex vivo and in vivo skin.  -:120262. 2021-01-01
• Isotretinoin-Delonix polymeric nanoparticles: Potentials for skin follicular targeting in acne treatment.  610:121217. 2021-01-01
• Lipid nanocapsules loaded with prilocaine and lidocaine and incorporated in gel for topical application.  602:120675. 2021-01-01
• Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial.  609:121159. 2021-01-01
• Multicomponent ionic crystals of diltiazem with dicarboxylic acids toward understanding the structural aspects driving the drug-release.  605:120790. 2021-01-01
• Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: a design of experiments (DoE) approach.  597:120331. 2021-01-01
• Nanotechnology-based lipid systems applied to resistant bacterial control: A review of their use in the past two decades.  603:120706. 2021-01-01
• Neonatal and pediatric oral drug delivery: Hopes and hurdles.  597:120296. 2021-01-01
• Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.  17:120714. 2021-01-01
• Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride.  606:120885. 2021-01-01
• Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a new approach for the treatment of pulmonary arterial hypertension.  610:121181. 2021-01-01
• Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension.  610:121181. 2021-01-01
• P-selectin targeting polysaccharide-based nanogels for miRNA delivery.  597:120302. 2021-01-01
• PEGylated LyeTx I-b peptide is effective against carbapenem-resistant Acinetobacter baumannii in an in vivo model of pneumonia and shows reduced toxicity.  1:121156-121170. 2021-01-01
• Physiologically relevant dissolution conditions towards improved in vitro - in vivo relationship - A case study with enteric coated pantoprazole tablets.  .:120857. 2021-01-01
• Polymeric-based drug delivery systems for veterinary use: State of the art.  604:120756. 2021-01-01
• Polymorphism characterization of segesterone acetate: A comprehensive study using XRPD, FT-IR and Raman spectroscopy.  596:120234. 2021-01-01
• Prolonged anesthesia and decreased toxicity of enantiomeric-excess bupivacaine loaded in ionic gradient liposomes.  606:120944. 2021-01-01
• Pullulan film incorporated with nanocapsules improves pomegranate seed oil anti-inflammatory and antioxidant effects in the treatment of atopic dermatitis in mice.  609:121144. 2021-01-01
• Sonodynamic therapy: Ultrasound parameters and in vitro experimental configurations.  610:121243. 2021-01-01
• Stabilization of vitamin C in emulsions of liquid crystalline structures.  592:120092. 2021-01-01
• The biofilm inhibition activity of a NO donor nanosilica with enhanced antibiotics action.  1:121220-12. 2021-01-01
• The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.  602:120607. 2021-01-01
• Therapeutic nanoparticles in the brain: a review of types, physicochemical properties and challenges.  612:121367-121380. 2021-01-01
• Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.  595:120245. 2021-01-01
• Tiny dexamethasone palmitate nanoparticles for intravitreal injection: optimization and in vivo evaluation.  000:120509. 2021-01-01
• Transbuccal delivery of metal complexes of isoniazid as an alternative to overcome antimicrobial resistance problems.  590:119924. 2021-01-01
• Transdermal release of methotrexate by cationic starch/poly(vinyl alcohol)-based films as an approach for rheumatoid arthritis treatment.  611:121285. 2021-01-01
• p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.  141:120658. 2021-01-01
• A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization.  586:119390-xx. 2020-01-01
• Advances and challenges in nanocarriers and nanomedicines for veterinary application.  580:119214. 2020-01-01
• Application and Limitations of Thermogravimetric Analysis to Delineate the Hot Melt Extrusion Chemical Stability Processing Window.  590:119916. 2020-01-01
• Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation.  585:119474. 2020-01-01
• Buclizine crystal forms: First Structural Determinations, counter-ion stoichiometry, hydration, and physicochemical properties of pharmaceutical relevance.  589:119840. 2020-01-01
• Cancer treatment in the lymphatic system: A prospective targeting employing nanostructured systems.  587:119697-119697. 2020-01-01
• Current applications of drug delivery nanosystems associated with antimicrobial photodynamic therapy for oral infections.  1:120078-16. 2020-01-01
• Cutting-edge advances in therapy for the posterior segment of the eye: Solid lipid nanoparticles and nanostructured lipid carriers.  1:1-119831. 2020-01-01
• Dendrimers in the context of nanomedicine.  573:118814. 2020-01-01
• Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.  576:118997. 2020-01-01
• Double membrane based on lidocaine-coated polymyxin-alginate nanoparticles for wound healing: in vitro characterization and in vivo tissue repair.  591:120001. 2020-01-01
• EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles.  320:120082. 2020-01-01
• Effects of a novel roflumilast and formoterol fumarate dry powder inhaler formulation in experimental allergic asthma.  1:119771-119790. 2020-01-01
• Enhancing the solubility and permeability of the diuretic drug furosemide via multicomponent crystal forms.  587:119694-119705. 2020-01-01
• Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs.  588:119741. 2020-01-01
• Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy.  1:119336. 2020-01-01
• Evolution of supersaturation from amorphous solid dispersions in water-insoluble polymer carriers: Effects of swelling capacity and interplay between partition and diffusion.  581:119292. 2020-01-01
• Extracellular Vesicles Derived from Plasmodium-infected and Non-infected Red Blood Cells as Targeted Drug Delivery Vehicles.  xx:119627. 2020-01-01
• Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.  581:119283. 2020-01-01
• Hot melt-extrusion improves the properties of cyclodextrin-based poly (pseudo)rotaxanes for transdermal formulation.  586:1-11. 2020-01-01
• In vitro - in vivo correlation in the development of oral drug formulation: A screenshot of the last two decades.  580:119210. 2020-01-01
• Iontophoresis enhances voriconazole antifungal potency and corneal penetration.  576:118991. 2020-01-01
• Levan-based nanostructured systems: an overview.  580:119242. 2020-01-01
• Nanotechnological strategies for systemic microbial infections treatment: A review.  1:119780-119813. 2020-01-01
• Neuroprotection by curcumin: a review on brain delivery strategies.  1:119476. 2020-01-01
• Novel iron oxide nanocarriers loading finasteride or dutasteride: enhanced skin penetration for topical treatment of alopecia.  587:119709. 2020-01-01
• Omeprazole nanoparticles suspension: development of a stable liquid formulation with a view to pediatric administration.  589:01-10. 2020-01-01
• One-step extrusion of concentrated lidocaine lipid nanocarrier (LNC) dispersions.  x:119817. 2020-01-01
• Optimization of the supercritical fluidized bed process for sirolimus coating and drug release.  589:119809. 2020-01-01
• Poloxamer micellar system for intra-articular injection of 15-deoxy-delta 12,14-prostaglandin J2 with improved bioavailability and anti-inflammatory properties in the temporomandibular joint of rats.  583:119383. 2020-01-01
• Predictive models of FDM 3D printing using experimental design based on pharmaceutical requirements for tablet production.  588:119728. 2020-01-01
• Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity.  589:119764. 2020-01-01
• Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections.  10:1-13. 2020-01-01
• Red pepper peptide coatings control Staphylococcus epidermidis adhesion and biofilm formation.  574:118872. 2020-01-01
• Spray-dried raloxifene submicron particles for pulmonary delivery: development and in vivo pharmacokinetic evaluation in rats.  585:119429. 2020-01-01
• Synthesis of cationic quaternized pullulan derivatives for miRNA delivery.  577:119041. 2020-01-01
• The prominence of the dosage form design to treat ocular diseases.  586:119577-119577-13. 2020-01-01
• The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.  589:119832. 2020-01-01
• Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.  588:119734. 2020-01-01
• Toxicity of topically applied drugs beyond skin irritation: Static skin model vs. Two organs-on-a-chip.  1:119788. 2020-01-01
• Transbuccal delivery of metal complexes of isoniazid as an alternative to overcome antimicrobial resistance problems.  590:119924. 2020-01-01
• Unplanned absorption of sunscreen ingredients: Impact of formulation and evaluation methods.  591:120013. 2020-01-01
• Viscosity of API/fatty acid suspensions: Pitfalls during analysis.  584:119447. 2020-01-01

tem uma área de assunto

• ASTRONOMIA / FISICA
• BIODIVERSIDADE
• BIOTECNOLOGIA
• CIENCIA DE ALIMENTOS
• CIENCIAS AGRARIAS I
• CIENCIAS AMBIENTAIS
• CIENCIAS BIOLOGICAS I
• CIENCIAS BIOLOGICAS II
• CIENCIAS BIOLOGICAS III
• ECONOMIA
• ENGENHARIAS II
• ENGENHARIAS IV
• FARMACIA
• GEOCIENCIAS
• INTERDISCIPLINAR
• MATERIAIS
• MEDICINA I
• MEDICINA II
• MEDICINA III
• MEDICINA VETERINARIA
• ODONTOLOGIA
• PSICOLOGIA
• QUIMICA
• SAUDE COLETIVA

publisher

• Elsevier BV

is open access

• False invalid format

is in DOAJ

• False invalid format

2 year mean citedness

• 5.857725419120979

H index

• 255

i10 index

• 15891

ISSN-L

• 0378-5173

openalex identifier

• https://openalex.org/S131016564

International Standard Serial Number (ISSN)

• 0378-5173
• 1873-3476